There is a risk of medication errors due to the presence on the market of different cabazitaxel presentations: - Glenmark Cabazitaxel 20 mg/ml and Cabazitaxel 10 mg/ml concentrate for solution for infusion requires a single-step dilution process; - Jevtana 60 mg/1.5 ml concentrate (10 mg/ml after first dilution) and solvent for solution for infusion requires a two-step dilution process.